alexa Up To Date Advances In Nano-carrier Systems For Oral Delivery Of Antidiabetic Peptides
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

13th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology
July 24-25, 2017 | Rome, Italy

Ruba Ismail and I Csoka
University of Szeged, Hungary
ScientificTracks Abstracts: J Nanomed Nanotechnol
DOI: 10.4172/2157-7439-C1-049
Abstract
Current progresses in pharmaceutical biotechnology have led to the discovery of numerous antidiabetic peptides. Nevertheless, these drugs like insulin, GLP-1 and its analogs are currently administrated parenterally, a route which is not well accepted by patients, and also does not mimic the endogenous pathway of insulin or GLP-1 secretion. Aiming to overcome the various disadvantages of this delivery route, tremendous efforts have been recently devoted for oral antidiabetic peptides administration. Based on the evaluation of recently published papers, it can be concluded that among numerous approaches to enhance the antidiabetic peptide oral bioavailability, much of the success was recorded using different nanocarrier systems including solid lipid nanoparticles, micelles, polymeric nanoparticles, liposomes and nanoemulsions. A successful nanocarrier should protect the peptide from the harsh environment within the GIT, and facilitate both mucus permeation and epithelial absorption. Besides, there is an integral need to prove that the benefits of these nanosystems overweight their risks, further in vivo and human studies must be conducted to know more about the effect of these carriers on the pharmacokinetics and efficacy of antidiabetic drugs. Despite these significant research efforts, there is still no FDA approved oral insulin or GLP-1 analog on the market. Thus, research in this area should be continued at even a higher pace to access a safe and effective nanosystem that could be completely accepted for chronic treatment of diabetes. This review emphasizes the challenges, advantages and limitations of different possibilities with a critical thinking and aiming to select the proper way for further steps in the field.
Biography

Ruba Ismail has completed her Master’s study in Pharmaceutical Sciences in 2015 from Tishreen University, Latakia, Syria. Presently, she is a 1st year PhD student at Szeged University, Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, Szeged, Hungary.

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords